SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-054707
Filing Date
2020-10-13
Accepted
2020-10-13 17:52:06
Documents
2
Period of Report
2020-10-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1627
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4310
  Complete submission text file 0001209191-20-054707.txt   7288
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Issuer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address PORTOLA PHARMACEUTICALS, INC. 270 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Dier Mardi (Reporting) CIK: 0001574591 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36276 | Film No.: 201237564